RE: Too many false negatives from....20 Apr 2021 23:12
I ment collaborations not contracts..
Look at these.. BRH need to deliver something soon.. Time waits for no man..
Global distribution agreement with ABCAM plc to sell Avacta'sSARS-CoV-2 research ELISA1 Affimer® reagents
Avacta's next generation cell and gene therapy joint venture with Daewoong Pharmaceutical secures Series A venture funding
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has entered into a collaboration agreement with Bruker Corporation (Billerica, MA) (NASDAQ: BRKR, "Bruker") to evaluate the Affimer-based, bead assisted mass spectrometry ("BAMSTM") SARS-CoV-2 assay, that the Group has developed with Adeptrix Inc. (Beverley, MA) ("Adeptrix").